ESC 365 - Doctor Andrea Rubboli

Speaker illustration

Doctor Andrea Rubboli

SANTA MARIA DELLE CROCI RAVEN Hospital, Ravenna (Italy)

Member of:

Andrea Rubboli, MD, FESC is the Director of the Division of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy. After earning cum laude both his MD degree and specialization in Cardiology at the University of Bologna Medical School, Italy, he completed subsequent training at Loyola University of Chicago, IL, USA and University of Linköping, Sweden. He has long been interested in the diagnosis and treatment of thrombotic and thromboembolic diseases, and has pioneered the field of antithrombotic treatment of patients with indication for oral anticoagulation, in particular atrial fibrillation, undergoing percutaneous coronary intervention. On this issue, a substantial scientific contribution (also through national and international collaborations) has been produced, leading to the acquisition of international reputation, constant invitation as faculty member to the most important congresses, and involvement in the development of guidelines/international consensus documents.

Sessions Presentations Events Articles

Meet the Experts: de-escalating DAPT in acute coronary syndrome patients to reduce bleeding risk – what safe options do I have?

Event: ESC Congress 2023

Topic: Cardiovascular Pharmacotherapy

Session type: Meet the Experts

Young Investigator Awards Session in Thrombosis

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Award Sessions

Poster awards and closure of conference

Event: EuroThrombosis and EuroVessels 2022

Topic: Thrombosis, Bleeding

Session type: Teaching Course

Thrombosis and anticoagulation in valvular heart disease

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session type: Moderated ePosters

Young Investigator Awards Session in Thrombosis

Event: ESC Congress 2022

Topic: European Society of Cardiology

Session type: Award Sessions

Optimizing antithrombotic therapy in elderly atrial fibrillation patients undergoing percutaneous coronary intervention: choosing the right regimen and oral anticoagulant

Event: ESC Congress 2019

Topic: Treatment

Session type: Practical Tutorials

Optimal surrogate endpoints of drug response

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Moderated Posters

ESC 365 is supported by